1
|
Giraldo-Cadavid LF, Echeverry J, Varón-Vega F, Bastidas A, Ramírez-Jaime A, Cardona AF, Lopez Vega CJ, Serrano-Mayorca CC, Garay D, Rincón DN, Oliveros H, Ramírez IA, Garcia-Gallo E, Enciso-Prieto VA, Ibáñez-Prada ED, Camelo JC, Cucunubo L, Buitrago L, Paipa LA, Longas LC, Agudelo-Otálora LM, Porras Diaz NF, Rachid RR, Henao I RD, Pedraza S, Reyes LF. The development and implementation of a low-cost mechanical ventilator in a low-middle-income country during the COVID-19 pandemic: The Unisabana-HERONS. Heliyon 2024; 10:e30671. [PMID: 38756610 PMCID: PMC11096896 DOI: 10.1016/j.heliyon.2024.e30671] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2023] [Revised: 04/02/2024] [Accepted: 05/01/2024] [Indexed: 05/18/2024] Open
Abstract
Background The COVID-19 pandemic in Latin America generated the need to develop low-cost, fast-manufacturing mechanical ventilators. The Universidad de La Sabana and the Fundacion Neumologica Colombiana designed and manufactured the Unisabana-HERONS (USH) ventilator. Here, we present the preclinical and clinical study results to evaluate its effectiveness and safety characteristics in an animal model (Yorkshire Sow) and five patients with acute respiratory failure receiving mechanical ventilatory support for 24 h. Methods The effectiveness and safety outcomes included maintaining arterial blood gases and pulse oximetry saturation (SpO2), respiratory pressures and volumes (during continuous monitoring) in the range of ARDS and lung-protective strategy goals, and the occurrence of barotrauma. A significance level of 0.05 was used for statistical tests. This clinical trial was registered on Clinicaltrials.gov (NCT04497623) and approved by the ethics committee. Results Among patients treated with the Unisabana-HERONS, the most frequent causes of acute respiratory failure were pneumonia in 3/5 (60 %) and ARDS in 2/5 (40 %). During the treatment, the ventilatory parameters related to lung protection protocols were kept within the safety range, and vital signs and blood gas were stable. The percentage of time that the respiratory pressures or volumes were out of safety range were plateau pressure >30 cm H2O: 0.00 %; driving pressure >15 cm H2O: 0.06 %; mechanical power >15 J/min: 0.00 %; and Tidal volume >8 mL/kg: 0.00 %. There were no adverse events related to the ventilator. The usability questionnaire retrieved a median score for all items between 9 and 10 (best score: 10), indicating great ease of use. Conclusion The Unisabana-HERONS ventilator effectively provided adequate gas exchange and maintained the ventilatory parameters in the range of lung protection strategies in humans and an animal model. Furthermore, it is straightforward to use and is a low-cost medical device.
Collapse
Affiliation(s)
| | | | - Fabio Varón-Vega
- Fundación Neumológica Colombiana, Bogotá, Colombia
- Universidad de Navarra, Pamplona, Spain
| | | | - Andrés Ramírez-Jaime
- Universidad de La Sabana, Chía, Colombia
- Universidad de Los Andes, Bogotá, Colombia
| | | | - Cristian Joao Lopez Vega
- Fundación Clínica Shaio, Bogotá, Colombia
- Fundación Cardioinfantil Instituto de Cardiología, Bogotá, Colombia
- Universidad Nacional de Colombia, Bogotá, Colombia
| | | | - Diana Garay
- Universidad de La Sabana, Chía, Colombia
- Clínica Universidad de La Sabana, Chía, Colombia
| | | | | | | | | | | | - Elsa D. Ibáñez-Prada
- Universidad de La Sabana, Chía, Colombia
- Clínica Universidad de La Sabana, Chía, Colombia
| | | | | | | | | | | | | | | | | | | | - Santiago Pedraza
- Universidad de La Sabana, Chía, Colombia
- Clínica Universidad de La Sabana, Chía, Colombia
| | - Luis Felipe Reyes
- Universidad de La Sabana, Chía, Colombia
- Clínica Universidad de La Sabana, Chía, Colombia
- Pandemic Sciences Institute, University of Oxford, Oxford, United Kingdom
| |
Collapse
|
2
|
LaChance J, Schottdorf M, Zajdel TJ, Saunders JL, Dvali S, Marshall C, Seirup L, Sammour I, Chatburn RL, Notterman DA, Cohen DJ. PVP1-The People's Ventilator Project: A fully open, low-cost, pressure-controlled ventilator research platform compatible with adult and pediatric uses. PLoS One 2022; 17:e0266810. [PMID: 35544461 PMCID: PMC9094548 DOI: 10.1371/journal.pone.0266810] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2021] [Accepted: 03/28/2022] [Indexed: 12/03/2022] Open
Abstract
Mechanical ventilators are safety-critical devices that help patients breathe, commonly found in hospital intensive care units (ICUs)-yet, the high costs and proprietary nature of commercial ventilators inhibit their use as an educational and research platform. We present a fully open ventilator device-The People's Ventilator: PVP1-with complete hardware and software documentation including detailed build instructions and a DIY cost of $1,700 USD. We validate PVP1 against both key performance criteria specified in the U.S. Food and Drug Administration's Emergency Use Authorization for Ventilators, and in a pediatric context against a state-of-the-art commercial ventilator. Notably, PVP1 performs well over a wide range of test conditions and performance stability is demonstrated for a minimum of 75,000 breath cycles over three days with an adult mechanical test lung. As an open project, PVP1 can enable future educational, academic, and clinical developments in the ventilator space.
Collapse
Affiliation(s)
- Julienne LaChance
- Department of Mechanical and Aerospace Engineering, Princeton University, Princeton, New Jersey, United States of America
| | - Manuel Schottdorf
- Princeton Neuroscience Institute, Princeton University, Princeton, New Jersey, United States of America
| | - Tom J. Zajdel
- Department of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States of America
| | - Jonny L. Saunders
- Department of Psychology and Institute of Neuroscience, University of Oregon, Eugene, Oregon, United States of America
| | - Sophie Dvali
- Department of Physics, Princeton University, Princeton, New Jersey, United States of America
| | - Chase Marshall
- RailPod, Inc., Boston, Massachusetts, United States of America
| | - Lorenzo Seirup
- New York ISO, Rensselaer, New York, United States of America
| | - Ibrahim Sammour
- Department of Neonatology, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, United States of America
| | - Robert L. Chatburn
- Department of Neonatology, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, United States of America
| | - Daniel A. Notterman
- Department of Molecular Biology, Princeton University, Princeton, New Jersey, United States of America
| | - Daniel J. Cohen
- Department of Mechanical and Aerospace Engineering, Princeton University, Princeton, New Jersey, United States of America
| |
Collapse
|
3
|
White LA, Maxey BS, Solitro GF, Takei H, Conrad SA, Alexander JS. Efficacy and safety testing of a COVID-19 era emergency ventilator in a healthy rabbit lung model. BMC Biomed Eng 2022; 4:2. [PMID: 35287761 PMCID: PMC8919917 DOI: 10.1186/s42490-022-00059-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2021] [Accepted: 02/21/2022] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND The COVID-19 pandemic revealed a substantial and unmet need for low-cost, easily accessible mechanical ventilation strategies for use in medical resource-challenged areas. Internationally, several groups developed non-conventional COVID-19 era emergency ventilator strategies as a stopgap measure when conventional ventilators were unavailable. Here, we compared our FALCON emergency ventilator in a rabbit model and compared its safety and functionality to conventional mechanical ventilation. METHODS New Zealand white rabbits (n = 5) received mechanical ventilation from both the FALCON and a conventional mechanical ventilator (Engström Carestation™) for 1 h each. Airflow and pressure, blood O2 saturation, end tidal CO2, and arterial blood gas measurements were measured. Additionally, gross and histological lung samples were compared to spontaneously breathing rabbits (n = 3) to assess signs of ventilator induced lung injury. RESULTS All rabbits were successfully ventilated with the FALCON. At identical ventilator settings, tidal volumes, pressures, and respiratory rates were similar between both ventilators, but the inspiratory to expiratory ratio was lower using the FALCON. End tidal CO2 was significantly higher on the FALCON, and arterial blood gas measurements demonstrated lower arterial partial pressure of O2 at 30 min and higher arterial partial pressure of CO2 at 30 and 60 min using the FALCON. However, when ventilated at higher respiratory rates, we observed a stepwise decrease in end tidal CO2. Poincaré plot analysis demonstrated small but significant increases in short-term and long-term variation of peak inspiratory pressure generation from the FALCON. Wet to dry lung weight and lung injury scoring between the mechanically ventilated and spontaneously breathing rabbits were similar. CONCLUSIONS Although conventional ventilators are always preferable outside of emergency use, the FALCON ventilator safely and effectively ventilated healthy rabbits without lung injury. Emergency ventilation using accessible and inexpensive strategies like the FALCON may be useful for communities with low access to medical resources and as a backup form of emergency ventilation.
Collapse
Affiliation(s)
- Luke A White
- Department of Molecular & Cellular Physiology, LSU Health Shreveport, 1501 Kings Highway, Shreveport, LA, 71103-3932, USA
| | - Benjamin S Maxey
- Department of Molecular & Cellular Physiology, LSU Health Shreveport, 1501 Kings Highway, Shreveport, LA, 71103-3932, USA
| | - Giovanni F Solitro
- Department of Orthopedic Surgery, LSU Health Shreveport, Shreveport, LA, USA
| | - Hidehiro Takei
- Department of Pathology, LSU Health Shreveport, Shreveport, LA, USA
| | - Steven A Conrad
- Department of Medicine, LSU Health Shreveport, Shreveport, LA, USA
- Department of Emergency Medicine, LSU Health Shreveport, Shreveport, LA, USA
- Department of Pediatrics, LSU Health Shreveport, Shreveport, LA, USA
| | - J Steven Alexander
- Department of Molecular & Cellular Physiology, LSU Health Shreveport, 1501 Kings Highway, Shreveport, LA, 71103-3932, USA.
- Department of Medicine, LSU Health Shreveport, Shreveport, LA, USA.
- Department of Neurology, LSU Health Shreveport, Shreveport, LA, USA.
| |
Collapse
|